Sutro to Present at 37th Annual J.P. Morgan Healthcare Conference
January 3, 2019
SOUTH SAN FRANCISCO, Calif., Jan. 3, 2019 –Sutro Biopharma, Inc. (NASDAQ: STRO) today announced that Bill Newell, Chief Executive Officer, will present at the 37th.. Read More →
Sutro to Participate in the 30th Annual Piper Jaffray Healthcare Conference
November 26, 2018
SOUTH SAN FRANCISCO, Calif., Nov. 26, 2018 — Sutro Biopharma, Inc. (Nasdaq: STRO), a clinical-stage drug discovery, development and manufacturing company focused on the application.. Read More →
Cancer’s Next-Gen Smart Bomb: Who Will Be First To Weaponize? – InVivo
June 1, 2017
https://invivo.pharmamedtechbi.com/IV005100/Cancers-NextGen-Smart-Bomb-Who-Will-Be-First-To-Weaponize .. Read More →
Biotechnology: Saving Lives & Transforming Healthcare in the 21st Century
May 4, 2017
Modern biotechnology is a young industry. But in just a few decades, the entrepreneurs, scientists, researchers and investors working in this field have firmly established themselves.. Read More →
BioTech Nation Radio with CEO Bill Newell
November 10, 2016
NPR and BioTech Nation interview Sutro’s CEO William Newell to learn more about the next generation of cancer therapeutics. Click here to listen to the.. Read More →
Sutro Biopharma Receives the Pantheon 2015 DiNA Outstanding Partner Award by the California Life Sciences Association
November 18, 2015
SAN FRANCISCO, Nov. 18, 2015 /PRNewswire/ — Sutro Biopharma today announced that it was awarded the Outstanding Partner Award, at the California Life Sciences Association (CLSA) annual Pantheon.. Read More →
FierceBiotech names Sutro Biopharma as one of its “Fierce 15” Biotech Companies of 2014
September 22, 2014
San Francisco, CA – September 22, 2014 – Sutro Biopharma today announced that it has been named by FierceBiotech as one of 2014’s Fierce.. Read More →
Sutro Biopharma’s Xpress CF Technology Nominated for Best Scientific Innovation by World ADC
July 1, 2014
On July 1, 2014, World ADC announced the nominees for the World ADC Awards, 2014. Sutro Biopharma’s cell free expression system, Xpress CF™, has made.. Read More →
EnWave Signs Commercial License with Sutro Biopharma for powderREV® Technology
July 1, 2014
Press release published by EnWave Corporation regarding the recent agreement with Sutro Biopharma, Inc. Read more.. Read More →
Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter
July 4, 2013
Scientific American Guest Blog Antibody-Drug Conjugates and Cancer Treatment: Making “Smart Bombs” Smarter By: Trevor J. Hallam Read More.. Read More →
Sutro Biopharma’s Trevor Hallam offers a glimpse into the future of drug design
December 5, 2011
12/5/2011 – BioPharm International Podcast (3of3): Sutro Biopharma’s Trevor Hallam offers a glimpse into the future of drug design By: Trevor J. Hallam.. Read More →
Sutro Biopharma’s Trevor Hallam describes a future cGMP manufacturing facility
November 29, 2011
BioPharm International Podcast (2of3): Sutro Biopharma’s Trevor Hallam describes a future cGMP manufacturing facility By: Trevor J. Hallam.. Read More →
Sutro Biopharma and Cell-Free Protein Expression Systems
November 18, 2011
BioPharm International Podcast (1of3): Sutro Biopharma and Cell-Free Protein Expression Systems By: Trevor J. Hallam.. Read More →
Industrializing Design, Development, and Manufacturing of Therapeutic Proteins
May 1, 2011
PHARMACEUTICAL TECHNOLOGY Volume 35, pp. s8-s11 Industrializing Design, Development, and Manufacturing of Therapeutic Proteins By: Trevor J. Hallam, Christopher J. Murray... Read More →
“Unnatural Selection”
January 10, 2011
BioCentury, The Bernstein Report on BioBusiness January 10, 2011 issue article, “Unnatural Selection” in the Tools & Techniques section by BioCentury Senior Editor, Ms. Susan.. Read More →
Sutro Biopharma and Promising Protein Synthesis Technology
December 1, 2009
National Science Foundation (NSF) newsletter featuring Sutro Biopharma and Promising Protein Synthesis Technology. Read More.. Read More →